Bendazac

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Bendazac
Bendazac.svg
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Topical
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
ECHA InfoCard 100.039.594
Chemical and physical data
Formula C16H14N2O3
Molar mass 282.294 g/mol
3D model (Jmol)
 NYesY (what is this?)  (verify)

Bendazac (or bendazolic acid) is a non-steroidal anti-inflammatory drug used for joint and muscular pain.

Synthesis[edit]

Principal action is inhibition of protein denaturation.

Bendazac synthesis: BE 699226 ; G. Palazzo, U.S. Patent 3,470,194 (1967, 1969 both to Francesco Angelini).

Use of chloroacetamide in the alkylation step, followed by acid hydrolysis produces bendazac (instead of benzydamine).

See also[edit]

References[edit]